Suppression of Concanavalin A-Induced Hepatitis in IFN-γ-/- Mice, but Not in TNF-α-/- Mice: Role for IFN-γ in Activating Apoptosis of Hepatocytes

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1418-1428

  Tagawa, Yoh Ichi ^a   Sekikawa, Kenji ^b   Iwakura, Yoichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; FAS ANTIGEN; GAMMA INTERFERON; PLANT LECTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL HEPATITIS; APOPTOSIS; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CHIMERA; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CHIMERA; CONCANAVALIN A; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; HEPATITIS, ANIMAL; IMMUNE TOLERANCE; INTERFERON TYPE II; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLANT LECTINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031201023     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Steven, I. S., and J. M. Craig. 1991. Hepatic dysfunction due to cytokines. In Cytokines and Inflammation. E. S. Kimball, ed. CRC Press, London, pp. 235-273.
2. Kamimura, S., and H. Tsukamoto. 1995. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 22:1304.
3. Nanji, A. A., S. Zhao, S. M. Sadrzadeh, and D. J. Waxman. 1994. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 19:1483.
4. Wermers, G. W., H. Band, and E. J. Yunis. 1988. Role of the HLA system in antigen recognition and disease. In The Liver: Biology and Pathobiology, 2nd Ed. I. M. Arias, W. B. Jakoby, H. Popper, D. Schachter, and D. A. Shafritz, eds. Raven Press, New York, pp. 885.
5. Chisari, F. V. 1992. Hepatitis B virus biology and pathogensis. Mol. Genet. Med. 2:67.
6. Fukuda, R., N. Ishimura, T. X. Nguyen, A. Chowdhury, S. Ishihara, N. Kohge, S. Akagi, M. Watanabe, and S. Fukumoto. 1995. The expression of IL-2, IL-4 and interferon-γ (IFN-γ) mRNA using liver biopsies at different phases of acute exacerbation of chronic hepatitis B. Clin. Exp. Immunol. 100:446.
7. Morshed, S. A., H. Fukuma, Y. Kimura, S. Watanabe, and M. Nishioka. 1993. Interferon-γ, interleukin (IL)-2 and IL-2 receptor expressions in hepatitis C virus-infected liver. Gastroenterol. Jpn. 28:59.
8. Yoshioka, K., S. Kakumu, M. Arao, Y. Tsutsumi, and M. Inoue. 1989. Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 10:769.
9. Anastassakos, C., G. J. M. Alexander, R. A. Wolstencroft, J. A. Avery, B. C. Portmann, G. S. Panayi, D. C. Dumonde, A. L. W. F. Eddleston, and R. Williams. 1988. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 94:999.
10. Dienes, H. P., G. Hess, M. Woorsdorfer, S. Rossol, H. Gallati, G. Ramadori, and K.-H. M. Buschenfelde. 1991. Ultrastructural localization of interferon-producing cells in the livers of patients with chronic hepatitis B. Hepatology 13:321.
11. Gilles, P. N., D. L. Guerrette, R. J. Ulevitch, R. D. Schreiber, and F. V. Chisari. 1992. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-γ. Hepatology 16:655.
12. Toyonaga, T., O. Hino, S. Sugai, S. Wakasugi, K. Abe, M. Shichiri, and K. Yamamura. 1994. Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver. Proc. Natl. Acad. Sci. USA 91:614.
13. Katschinski, T., C. Galanos, A. Coumbos, and M. A. Freudenberg. 1992. Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect. Immun. 60:1994.
14. Nagakawa, J., I. Hishinuma, K. Hirota, K. Miyamoto, T. Yamanaka, K. Tsukdata, K. Katayama, and I. Ymatasu. 1990. Involvement of tumor necrosis factor-α in pathogenesis of activated macrophage-mediated hepatitis in mice. Gastroenterology 99:758.
15. Hishinuma, I., J. I. Nagakawa, K. Kirota, K. Miyamoto, K. Tsukidate, T, Yamanaka, K. I. Katayama, and I. Yamatsu. 1990. Involvement of tumor necrosis factor-α in development of hepatic injury in galactosamine-sensitized mice. Hepatology 12:1187.
16. Franks, A. K., K. I. Kujawa, and L. J. Yaffe. 1991. Experimental elimination of tumor necrois factor in low-dose endotoxin models has variable effects on survival. Infect. Immun. 59:2609.
17. Lehmann, V., M. A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657.
18. Galanos, C., M. A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76: 5939.
19. Decker, K., and D. Keppler. 1974. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71:77.
20. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457.
21. Car, B. D., V. M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumann, M. Aguet, and B. Ryffel. 1994. Interferon-γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179:1437.
22. Kamijo, R., D. Shapiro, J. Le, S. Huang, M. Aguet, and J. Vilcek. 1993. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon γ receptor. Proc. Natl. Acad. Sci. USA 90:6626.
23. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90:196.
24. Mizuhara, H., E. O'Neill, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, S. Satoh, M. Niwa, H. Senoh, and H. Fujiwara. 1994. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179:1529.
25. Ogasawara, J., R. Fukunaga-Watanabe, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806.
26. Gray, P. W., and D. V. Goeddel. 1983. Cloning and expression of murine immune interferon cDNA. Proc. Natl. Acad. Sci. USA 80:5842.
27. Nakamaye, K. L., and F. Eckstein. 1986. Inhibition of restriction endonuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis. Nucleic Acids Res. 14:9679.
28. Hall, C. V., P. E. Jacob, G. M. Ringold, and F. Lee. 1983. Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J. Mol. Appl. Genet. 2:101.
29. Azuma, S., and Y. Toyoda. 1990. Production of a germ-line chimeric mouse derived from newly established embryonic stem cells. Jpn. J. Anim. Reprod. 37:37.
30. Sawai, S., A. Shimono, K. Hanaoka, and H. Kondoh. 1991. Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. New Biol. 3:861.
31. Biggers, J. D., W. K. Whitten, and D. G. Whittingham. 1971. The culture of mouse embryo in vitro. In Methods in Mammalian Embryology. J. C. Daniel, Jr., ed. W. H. Freeman and Company, San Francisco, pp. 86-116.
32. Iwakura, Y., and M. Nozaki. 1985. Effects of tunicamycin on preimplantation mouse embryos: prevention of molecular differentiation during blastocyst formation. Dev. Biol. 112:135.
33. Wassarman, P. M., R. M. Greve, R. M. Perona, R. J. Roller, and G. S. Salzmann. 1984. How mouse eggs put on and take off their extracellular coat. In Molecular Biology of Development. E. Davidson and R. Firtel, eds. A. R. Liss, New York, p. 213.
34. Windebank, K. P., J. A. Faux, and H. M. Chapel. 1987. ELISA determination of IgG antibodies to pneumococcal capsular polysaccharides in a group of children. J. Immunol. Methods 104:143.
35. Yagi, T., T. Tokunaga, Y. Furuta, S. Nada, M. Yoshida, T. Tsukada, Y. Saga, N. Takeda, Y. Ikawa, and S. Aizawa. 1993. A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214:70.
36. Gavrieli, Y., Y. Sherman, and S. S. Ben. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493.
37. Cheomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
38. Pennica, D., J. S. Hayflick, T. S. Bringman, M. A. Palladino, and D. V. Goeddel. 1985. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82:6060.
39. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.
40. Ichii, Y., R. Fukunaga, S. Shiojiri, and Y. Sokawa. 1986. Mouse 2-5A synthetase cDNA: nucleotide sequence and comparison to human 2-5A synthetase. Nucleic Acids Res. 14:10117.
41. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
42. Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165:37.
43. Lippi, U., and G. Guidi. 1970. A new colorimetric ultramicromethod for serum glutamic-oxalacetic and glutamic-pyruvic transaminase determination. Clin. Chim. Acta 28:431.
44. Dalton, D. K., M. S. Pitts, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
45. Shulman, L., and M. Revel. 1980. Interferon-dependent induction of mRNA activity for (2′-5′)-oligoisoadenylate synthetase. Nature 298:98.
46. Kerr, J. F. R., W. G. E. Cooksley, J. Searle, J. W. Halliday, W. J. Halliday, L. Holder, I. Roberts, W. Burnett, and L. W. Powell. 1979. The nature of piece-meal necrosis in chronic active hepatitis. Lancet 2:827.
47. Searle, J., J. F. R. Kerr, and C. J. Bishop. 1982. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol. Annu. 17: 229.
48. Watanabe-Fukunaga, R., C. I. Brannan, N G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
49. Ferran, C., K. Sheehan, M. Dy, R. Schreiber, S. Merite, P. Landais, L. H. Noel, G. Grau, J. Bluestone, J. F. Bach, and L. Chatenoud. 1990. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur. J. Immunol. 20:509.
50. Lacronique, V., A. Mignon, M. Fabre, B. Viollet, N. Rouquet, T. Molina, A. Porteu, A. Henrion, D. Bouscary, P. Varlet, V. Joulin, and A. Kahn. 1996. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nature Medicine 2:80.
51. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
52. Suda, T., T. Takahashi, P. Goldstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
53. Galle, P. R., W. J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P. H. Krammer, and L. Runkel. 1995. Involvement of the CD95 (Apo-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223.
54. Morita, M., Y. Watanabe, and T. Akaike. 1995. Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. Hepatology 21:1585.
55. Lee, S. B., and M. Esteban. 1994. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199:491.
56. Deiss, L. P., E. Feinstein, H. Berissi, O. Cohen, and A. Kimchi. 1995. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ interferon-induced cell death. Genes Dev. 9:15.
57. Laskin, D. L., M. Rodriguez del Valle, D. E. Heck, S. M. Hwang, S. T. Ohnishi, S. K. Durham, N. L. Goller, and J. D. Laskin. 1995. Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression. Hepatology 22:223.
58. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306.
59. Leist, M., F. Gantner, I. Bohlinger, P. G. Germann, G. Tiegs, and A. Wendel. 1994. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 153:1778.
60. Mita, E., N. Hayashi, S. Iio, T. Takehara, T. Hijioka, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem. Biophys. Res. Commun. 204:468.